KFF Health NewsLean L·
FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
Read at KFF Health News →
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.

A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.